Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase II Study of Epothilone Analog BMS-247550 in Patients With Non-Small Cell Lung Cancer Who Have Failed First Line Platinum Based Chemotherapy

NCT00035516 is registered in ClinicalTrials.gov with R-Pharm as lead sponsor.

NCT NCT00035516
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00035516 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase II Study of Epothilone Analog BMS-247550 in Patients With Non-Small Cell Lung Cancer Who Have Failed First Line Platinum Based Chemotherapy
Lead sponsor
R-Pharm
Phase
Phase 2
Overall status
Completed
Start date
February 28, 2001
Completion date
April 30, 2004
Enrollment
Not reported
Sites
16

Conditions

As the registry lists them; a condition with its own page is linked.

carcinoma, non-small-cell lung